Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells

Virus Research

Volumn 172, Issue 1-2, 2013, Pages 15-23

  Iankov, Ianko D ^a   Penheiter, Alan R ^a   Griesmann, Guy E ^a   Carlson, Stephanie K ^a   Federspiel, Mark J ^a   Galanis, Evanthia ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antibody enhanced infection; Measles virus; Microglial cells

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; MEASLES VIRUS H PROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CELL PROTECTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HUMAN; MEASLES; MEASLES VIRUS; MICROGLIA; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SYNCYTIUM; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS PLAQUE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; CELL LINE; HUMANS; MEASLES VIRUS; MICE; NEUROGLIA; VIRAL PROTEINS;

MEASLES VIRUS;

EID: 84873750119     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.12.002     Document Type: Article

References (41)

1. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. Journal of Neuroimmunology 1990, 27(2-3):229-237.
2. Campbell A.M. Monoclonal antibody and immunosensor technology. In: Laboratory Techniques in Biochemistry and Molecular Biology 1991, vol. 23. Elsevier, Amsterdam.
3. Cathomen T., Buchholz C.J., Spielhofer P., Cattaneo R. Preferential initiation at the second AUG of the measles virus F mRNA: a role for the long untranslated region. Virology 1995, 214(2):628-632.
4. Centers for Disease Control and Prevention (CDC) Progress in global measles control, 2000-2010. Morbidity and Mortality Weekly Report 2012, 61(4):73-78.
5. Chen R.T., Markowitz L.E., Albrecht P., Stewart J.A., Mofenson L.M., Preblud S.R., Orenstein W.A. Measles antibody: reevaluation of protective titers. Journal of Infectious Diseases 1990, 162(5):1036-1042.
6. Griffin D. Measles virus. Fields Virology 2001, 1401-1441. Lippincott, Williams & Wilkins, Philadelphia, PA. fourth ed. D.M. Knipe, P.M. Howley (Eds.).
7. Dejnirattisai W., Jumnainsong A., Onsirisakul N., Fitton P., Vasanawathana S., Limpitikul W., Puttikhunt C., Edwards C., Duangchinda T., Supasa S., Chawansuntati K., Malasit P., Mongkolsapaya J., Screaton G. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010, 328(5979):745-748.
8. Dhiman N., Ovsyannikova I.G., Cunningham J.M., Vierkant R.A., Kennedy R.B., Pankratz V.S., Poland G.A., Jacobson R.M. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. Journal of Infectious Diseases 2007, 195(1):21-29.
9. Dingli D., Peng K.W., Harvey M.E., Greipp P.R., O'Connor M.K., Cattaneo R., Morris J.C., Russell S.J. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 2004, 103(5):1641-1646.
10. Dowd K.A., Pierson T.C. Antibody-mediated neutralization of flaviviruses: a reductionist view. Virology 2011, 411(2):306-315.
11. Duprex W.P., McQuaid S., Hangartner L., Billeter M.A., Rima B.K. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. Journal of Virology 1999, 73(11):9568-9575.
12. Giraudon P., Wild T.F. Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 1985, 144(1):46-58.
13. Halstead S.B., Mahalingam S., Marovich M.A., Ubol S., Mosser D.M. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infectious Diseases 2010, 10(10):712-722.
14. Haralambieva I.H., Ovsyannikova I.G., O'Byrne M., Pankratz V.S., Jacobson R.M., Poland G.A. A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. Vaccine 2011, 29(27):4485-4491.
15. Haralambieva I.H., Ovsyannikova I.G., Umlauf B.J., Vierkant R.A., Shane Pankratz V., Jacobson R.M., Poland G.A. Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine 2011, 29(48):8988-8997.
16. Haralambieva I.H., Ovsyannikova I.G., Vierkant R.A., Poland G.A. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity. Clinical and Vaccine Immunology 2008, 15(7):1054-1059.
17. Huisman W., Martina B.E., Rimmelzwaan G.F., Gruters R.A., Osterhaus A.D. Vaccine-induced enhancement of viral infections. Vaccine 2009, 27(4):505-512.
18. Iankov I.D., Haralambieva I.H., Galanis E. Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein. Vaccine 2011, 29(8):1710-1720.
19. Iankov I.D., Msaouel P., Allen C., Federspiel M.J., Bulur P.A., Dietz A.B., Gastineau D., Ikeda Y., Ingle J.N., Russell S.J., Galanis E. Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model. Breast Cancer Research and Treatment 2010, 122(3):745-754.
20. Iankov I.D., Pandey M., Harvey M., Griesmann G.E., Federspiel M.J., Russell S.J. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. Journal of Virology 2006, 80(17):8530-8540.
21. June R.A., Schade S.Z., Bankowski M.J., Kuhns M., McNamara A., Lint T.F., Landay A.L., Spear G.T. Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation. AIDS 1991, 5(3):269-274.
22. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256(5517):495-497.
23. Langfield K.K., Walker H.J., Gregory L.C., Federspiel M.J. Manufacture of measles viruses. Methods in Molecular Biology 2011, 737:345-366.
24. Leonard V.H., Sinn P.L., Hodge G., Miest T., Devaux P., Oezguen N., Braun W., McCray P.B., McChesney M.B., Cattaneo R. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. Journal of Clinical Investigation 2008, 118(7):2448-2458.
25. Lunnon K., Teeling J.L., Tutt A.L., Cragg M.S., Glennie M.J., Perry V.H. Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration. Journal of Immunology 2011, 186(12):7215-7224.
26. Meyer K., Ait-Goughoulte M., Keck Z.Y., Foung S., Ray R. Antibody-dependent enhancement of hepatitis C virus infection. Journal of Virology 2008, 82(5):2140-2149.
27. Mrkic B., Pavlovic J., Rülicke T., Volpe P., Buchholz C.J., Hourcade D., Atkinson J.P., Aguzzi A., Cattaneo R. Measles virus spread and pathogenesis in genetically modified mice. Journal of Virology 1998, 72(9):7420-7427.
28. Muller C.P., Schroeder T., Tu R., Brons N.H., Jung G., Schneider F., Wiesmüller K.H. Analysis of the neutralizing antibody response to the measles virus using synthetic peptides of the haemagglutinin protein. Scandinavian Journal of Immunology 1993, 38(5):463-471.
29. Nakahara J., Aiso S. Fc receptor-positive cells in remyelinating multiple sclerosis lesions. Journal of Neuropathology and Experimental Neurology 2006, 65(6):582-591.
30. Nitta T., Yagita H., Sato K., Okumura K. Expression of Fc gamma receptors on astroglial cell lines and their role in the central nervous system. Neurosurgery 1992, 31(1):83-87.
31. Ovsyannikova I.G., Jacobson R.M., Poland G.A. Variation in vaccine response in normal populations. Pharmacogenomics 2004, 5(4):417-427.
32. Quan Y., Möller T., Weinstein J.R. Regulation of Fcγ receptors and immunoglobulin G-mediated phagocytosis in mouse microglia. Neuroscience Letters 2009, 464(1):29-33.
33. Righi M., Mori L., De Libero G., Sironi M., Biondi A., Mantovani A., Donini S.D., Ricciardi-Castagnoli P. Monokine production by microglial cell clones. European Journal of Immunology 1989, 19(8):1443-1448.
34. Robinson W.E., Montefiori D.C., Mitchell W.M. Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. Virology 1990, 175(2):600-604.
35. Song M.K., Vindurampulle C.J., Capozzo A.V., Ulmer J., Polo J.M., Pasetti M.F., Barry E.M., Levine M.M. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins. Journal of Virology 2005, 79(15):9854-9861.
36. Suhrbier A., La Linn M. Suppression of antiviral responses by antibody-dependent enhancement of macrophage infection. Trends in Immunology 2003, 24(4):165-168.
37. Takada A., Feldmann H., Ksiazek T.G., Kawaoka Y. Antibody-dependent enhancement of Ebola virus infection. Journal of Virology 2003, 77(13):7539-7544.
38. Takada A., Kawaoka Y. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Reviews in Medical Virology 2003, 13(6):387-398.
39. Takeda A., Tuazon C.U., Ennis F.A. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 1988, 242(4878):580-583.
40. Ward B.J., Aouchiche S., Martel N., Bertley F.M., Bautista-Lopez N., Serhir B., Ratnam S. Measurement of measles virus-specific neutralizing antibodies: evaluation of the syncytium inhibition assay in comparison with the plaque reduction neutralization test. Diagnostic Microbiology and Infectious Disease 1999, 33(3):147-152.
41. Wynne A.M., Henry C.J., Huang Y., Cleland A., Godbout J.P. Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge. Brain, Behavior, and Immunity 2010, 24(7):1190-1201.